Together, these data suggest that IL-4 and IL-13 produced by ILC2s in the tumor niche promote M-MDSC-mediated suppression of anti-tumor immunity and IFNγ production, demonstrating the role of sustained innate signals in shaping the tumor microenvironment. The gene discussed is IL4; the disease is neoplasm.